A study of years appear remarkably similar to those for the general population between 60-80 years. " There are, however, discrepancies. Though "Alzheimer-type dementia" is present in some older DS patients, it does not occur with the same frequency as the plaques and tangles, nor is the degree of dementia predicted by the density of plaques and tangles.' Furthermore, despite the morphological similarities the genetic relationship between DS and AD remains unclear. In relatives of index cases with AD a raised frequency for DS, AD, and haematological malignancies has been found,12-'4 and an increased number of presenile dementia in relatives of DS probands was reported. '5 There is growing evidence that patients with AD of early onset and familial occurrence may have a predisposing locus on chromosome 21, while in families with senile onset such linkage could not be substantiated. '6 17 Patients 
Results
The age distribution of the whole patient sample is given in the figure. Table 1 shows the mean ages of the patient sample for dementia, extrapyramidal, and frontal signs. The mean age between female and male patients did not differ significantly. Fourteen DS patients (age range 27-67 years) were assessed to be demen- ted. Their mean age was significantly higher than that of the 40 non-demented DS patients.
The mean age of five demented DS patients with extrapyramidal signs was significantly higher than that of the nine demented patients without extrapyramidal involvement. Signs of frontal disinhibition were present in demented as well as in non-demented DS patients. The mean age of patients with palmomental reflex and of those with grasping reflex was significantly higher than that of the patients without these signs. In the extrapyramidal involvement rigid-hypokinetic signs prevailed (table 2) . Two further patients had oral dyskinesias, but were not included in the study as they were on current neuroleptic medication. Resting tremor and myoclonic jerks were not observed. No patient received levodopa treatment.
Other neurological signs unrelated to dementia were strabismus (n = 17), nystagmus (n = 3), pyramidal signs (n = 3), dysarthria (n= 1). Precocious ageing signs were: early grey hair (n = 5), cataract (n = 3), hypacousis (n = 2). Grand-mal epilepsy was present in seven patients (two demented); two patients had occasional seizures. Seizures were observed a few weeks before death in one patient. Two patients were on anticonvulsant medication. EEG was normal in 11 patients, mildly abnormal in 13, and moderately abnormal in 11 . None of the patients with seizures had epileptic discharges on the interictal EEG recording. There was no relation between severity of EEG changes and signs of frontal disinhibition or dementia.
Atrophic changes on CT were seen in two demented patients. Three non-demented patients had basal ganglia calcification, but no signs of extrapyramidal involvement.
No first-degree relatives with early-onset dementia (before 65 years) could be detected from the questionnaire. One mother had Parkinsonism before the age of 65. Among 149 firstand second-degree relatives older than 65 years two had senile dementia (mother, paternal grandfather), and two had Parkinsonism (father, paternal grandfather). Other single neurological disorders in first-degree relatives were essential tremor, glioma, meningioma, epilepsy, and DS (a brother).
Discussion Conclusions from our study should be drawn cautiously because of the methodological limitations in the clinical investigation of men- Resting or postural tremor was not observed in our sample, but had been present in four out of 10 DS patients with EP signs in another larger sample on dementia in DS.3' Two patients of that prospective investigation had Parkinsonism before the onset of dementia, whereas all of our DS patients with EP signs were demented. These patients were of a significantly higher age compared with those demented DS patients without EP involvement. It appears therefore from our study, that EP signs are features more likely to occur late in the clinical course ofdemented DS patients, but that such signs do not seem to be essential in the disease spectrum.
We found 36% of demented patients with EP signs in DS are in the range also found in AD patients.2>26 Others have described different percentages for their AD patients (9%;21 62%;18 65%;27 92%22)
The main clinical feature in our study was of the hypokinetic rigid type. This bears similarities to Parkinsonism encountered during the course of AD.'>27 In our DS series none of the patients had tremor at rest, which in AD has been observed in between 4"48%.1820222527 Dyskinesias in AD unrelated to neuroleptic medication have been seen in 17%,22 23%,20 and 38% . 25 In an unselected population of nondemented older people the rate was 38%.38 In order to clarify, if dyskinesias in DS are more frequently present than 14% (our series), a prospective lifetime study of the individual patients seems necessary.
The occurrence of EP signs in AD can be sufficiently related to pathological changes in the substantia nigra (SN).262930 Also in DS, several neuropathological and neurochemical theories can support the clinical findings.
First, it is obvious from ours and from previous studies, that calcification of the basal ganglia, which is frequently encountered in DS, does not play a pathogenetic role in the development of EP features. 39 The SN is less severely involved pathologically than other subcortical nuclei in young and middle aged DS patients, in contrast with AD.4' On the other hand, the brains of patients with advanced DS show more numerous neurofibrillar tangles than comparable AD brains and mild to moderate SN pathology suggesting Parkinsonism (Lewy bodies, neuromelanin deposits).42 Others, however, did not observe Lewy bodies in older DS patients. 43 Neurochemically the content of dopamine in the caudate nucleus and of homovanillic acid in the CSF is reduced in more advanced stages, while it is normal in young and middle aged DS patients.
Together, these findings support the finding that the pathological changes in the SN and the clinical presentation of Parkinsonism seem to be phenomena occurring late in the course of DS.
Why does the SN in DS seem to be afflicted so late in the disease compared with other regions of the brain and to a less severe degree than in AD? One should remember that the triplication of the chromosomal segment 2 1q22 is responsible for an overexpression of the gene for the copper/zinc-superoxide dismutase (Cu/ Zn-SOD). Such elevated gene dose may disturb the steady-state of active oxygen species within the cell, resulting in oxidative damage to biologically important molecules. It has been suggested that such a mechanism may in part be responsible for the mental retardation and for the AD pathology (that is, paired helical filament formation) associated with the DS phenotype.' Cu/Zn-SOD on the other hand catalyses the conversion of superoxide radicals to hydrogen peroxide. In Parkinson's disease hydrogen peroxide and related oxygen radicals may be involved in the degeneration of dopamine neurons.47 Cytosolic Cu/Zn-SOD-like activity and mitochondrial Mn-SOD-like activity are increased in the SN of Parkinsonian brains at necropsy. '49 In DS patients perhaps the excess of Cu/Zn-SOD serves as a protective mechanism in the SN by scavenging radicals occurring in nigral metabolism. This may result clinically in a Parkinsonian syndrome at a later stage and, possibly, to a lesser degree than expected from comparison with AD. It has been also shown that Cu/Zn-SOD protects against toxic effects of pyridinium derivates (for example, paraquat), that are currently considered to play a pathogenetic role in Parkinsonism.50
It may also be possible that overexpression of Cu/Zn-SOD in familial, early-onset AD could result in Parkinsonian features at a lesser degree and, probably a later stage, when compared with those AD cases without linkage to chromosome 21.
As mentioned earlier, there is a clinical and pathological overlap mainly in the late stages in AD and PD. A recent family study reported an increased risk for AD and for PD among the relatives of probands with AD.28 Previous pedigree analyses of index patients with AD suggesting an increased risk in their relatives to suffer from AD, DS, and/or haematological malignancies have been criticised mainly on grounds of methodology and sample size.'2"4
As a raised frequency of presenile dementia in relatives of DS patients has been reported, '5 we undertook a similar, questionnaire-based inquiry on dementia and additionally on PD signs in the families of our DS patients. There was no increased rate of dementia with onset before the age of 65 years. Two senile-onset demented relatives among 149 persons at risk does not greatly exceed that expected from the age-specific prevalence rate for dementia over 65 years of age in the general population (0-65%),5 (2 x 100): 149 = 1-34%. Thesame applies for two relatives with senile-onset (after age 65 years) PD, given the similar age-specific prevalence rates for dementia in the seventh and eighth decade of life.
Thus our data do not provide better evidence of the relative risk of AD and PD in families with DS probands. This is mostly because the sample is small, the method was questionnairebased, and diagnostic proof of the cases at risk was not possible.
This investigation has shown that extrapyramidal signs may be a feature of advanced DS. They were encountered only in demented DS patients. This finding parallels Alzheimer's disease, where such signs may also occur in an advanced stage, but to a greater degree. To evaluate the extrapyramidal involvement in DS may help to clarify the debated association between AD and PD, and further clinicopathological and neuro-chemical studies in DS patients may be useful. Such studies may gain additional interest considering the role of free-radical formation and its prevention in the pathophysiology of idiopathic Parkinson's disease. 
